188 studies found for:    "Diabetic Nephropathies"
Show Display Options
Rank Status Study
21 Completed Adiponectin and Insulin Resistance in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Losartan
22 Completed Effect of Pyridorin in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Pyridorin (pyridoxamine dihydrochloride)
23 Completed Effect of Pyridorin in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Pyridorin (pyridoxamine dihydrochloride)
24 Not yet recruiting Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Type 2 Diabetes
Intervention: Biological: Mesenchymal Precursor Cells (MPCs)
25 Recruiting Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy
Conditions: Diabetes Type 2;   Diabetic Nephropathy;   Vascular Disease
Interventions: Drug: Ramipril;   Drug: Clopidogrel
26 Completed Evaluating the Renoprotective Effect of Milk Thistle Extract on Patients With Type II Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: placebo;   Drug: Milk Thistle extract
27 Unknown  Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney Disease
Condition: Diabetic Nephropathies
Interventions: Drug: Moxonidine;   Drug: Placebo
28 Active, not recruiting Combined Diabetes-Renal Multifactorial Intervention In Patients With Advanced Diabetic Nephropathy (ADN)
Condition: Diabetic Nephropathy
Intervention: Other: Multifactorial Intervention
29 Unknown  Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study
Conditions: Diabetes;   Diabetic Nephropathy;   Renal Protection
Intervention: Drug: Rosiglitasone (retrospective observation)
30 Recruiting Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients
Condition: Diabetic Nephropathy
Interventions: Drug: Repository Corticotropin Injection;   Drug: Placebo
31 Completed
Has Results
ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial
Conditions: Diabetic Nephropathy;   Type 2 Diabetes Mellitus;   Proteinuria
Interventions: Drug: olmesartan medoxomil;   Drug: Placebo Tablets
32 Completed To Assess the Accuracy of the eZscan Study in the Screening for Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention:
33 Completed
Has Results
Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy
Conditions: Type 2 Diabetes;   Overt Diabetic Nephropathy
Interventions: Drug: Rosiglitazone;   Drug: Placebo
34 Completed Effect of Dietary Protein Restriction on Prognosis in Patients With Diabetic Nephropathy
Condition: Type 1 Diabetes Mellitus With Diabetic Nephropathy
Interventions: Dietary Supplement: low protein diet;   Dietary Supplement: normal protein diet
35 Active, not recruiting Low Protein Diet Supplemented With Ketoanalogs on Reducing Proteinuria and Maintaining Nutritional Status in Type 2 Diabetic Nephropathy
Condition: Type 2 Diabetic Nephropathy
Intervention: Dietary Supplement: Compound α-Ketoacid Tablet
36 Recruiting A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria
Condition: Diabetic Nephropathy
Interventions: Drug: MT-3995 Low;   Drug: MT-3995 High;   Drug: Placebo
37 Completed
Has Results
The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors
Conditions: Diabetic Nephropathy;   Chronic Kidney Disease
Interventions: Drug: Zemplar (paricalcitol ) capsules;   Drug: Zemplar (paricalcitol) capsules;   Drug: Placebo
38 Recruiting A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR
Condition: Diabetic Nephropathy
Interventions: Drug: MT-3995 Low;   Drug: MT-3995 High;   Drug: Placebo
39 Completed Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus
Condition: Macroalbuminuric Diabetic Nephropathy
Interventions: Drug: enalapril;   Drug: losartan
40 Terminated Effect of Low Protein Diet in Preventing the Progression of Diabetic Nephropathy
Condition: Diabetic Nephropathies
Intervention: Behavioral: low protein diet

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years